FDA Approves Ipilimumab, An Immunotherapy, To Treat Metastatic Melanoma

Friday, March 25, 2011 - 14:00 in Health & Medicine

Ipilimumab, a monoclonal antibody, received FDA approval today to treat advanced melanoma. This first-in-class antibody drug may also significantly improve standard cancer treatments.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net